Laurus Labs Limited — Director's Dealing 2021

Mar 4, 2021

==> picture [114 x 37] intentionally omitted <==

LAURUS LABS LIMITED

LAURUS LABS PROMOTERS, DR.SATYANARAYANA CHAVA, FOUNDER AND CEO & MRS. NAGARANI CHAVA, PROMOTER, ARE SET TO RELEASE THE PLEDGE OF SHARES OF THE COMPANY.

Hyderabad, March 04, 2021: Laurus Labs Ltd. (Laurus BSE: 540222, NSE: LAURUSLABS, ISIN: INE947Q01028), a leading research & development-driven and fully integrated pharmaceutical Company in India, announces that

Dr.Satyanarayana Chava, Founder Promoter, CEO & ED, sold 52 lakh equity shares of the Company today in the stock market at an average price of INR.368.59, per share, aggregating to INR 191.67 Crores and Mrs. Nagarani Chava, one of the promoters of the company sold 18 Lakh equity shares of the Company at an average price of 366.91 per share at an aggregate value of INR 66.04 Crores, together 1.3% of the paid up capital of the Company.

Significant part of the above amount shall be utilized to release the pledge on their equity shares of the Company.

It may be recalled that the above promoters have purchased around 3% of the then paid up capital of the Company in the year 2018.

-ENDS-

About Laurus Labs Limited

Laurus Labs is a leading research-driven Pharmaceutical Manufacturing Company in India. We have grown to become one of the leading manufacturers of API for Anti-Retroviral (ARV), Oncology, Cardiovascular, Anti-Diabetics, Anti-Asthma, and Gastroenterology. We are thriving on growth opportunities in formulation manufacturing to service all leading markets of North America, Europe, and Low Middle-Income Countries (LMIC). We are driving growth opportunities in Contract Development and Manufacturing through our Synthesis business. Most of our manufacturing facilities approved by major regulatory authorities, USFDA, WHO-Geneva, UK-MHRA, etc. Our approach remains to identify and invest ahead of time with strategic investments in Stateof-the-Art R&D and Manufacturing Infrastructure enabling us to become a quality supplier of high volume products. Corporate Identification No: L24239AP2005PLC047518

For more information about us, please visit http://www.lauruslabs.com or Contact particulars:

Pavan Kumar N

Laurus Labs Ltd. Tel: +91 40 6659 4380 Email: mediarelations@lauruslabs.com

==> picture [48 x 50] intentionally omitted <==

==> picture [68 x 58] intentionally omitted <==

DISCLAIMER: Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments and many other factors that could cause our actual results to differ materially from those contemplated by the relevant forward-looking statements. Laurus Labs Limited (Laurus) will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.

MARCH 4, 2021

Press Release